Edwards Lifesciences Corp. (EW)
107.18
+1.38
(+1.30%)
USD |
NYSE |
Nov 13, 16:00
107.18
0.00 (0.00%)
After-Hours: 19:59
Edwards Lifesciences Market Cap : 61.69B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 60.90B |
| November 11, 2026 | 60.90B |
| November 10, 2026 | 59.87B |
| November 09, 2026 | 60.27B |
| November 06, 2026 | 58.79B |
| November 05, 2026 | 58.03B |
| November 04, 2026 | 57.20B |
| November 03, 2026 | 54.79B |
| November 02, 2026 | 53.68B |
| October 30, 2026 | 53.05B |
| October 29, 2026 | 54.45B |
| October 28, 2026 | 52.92B |
| October 27, 2026 | 52.37B |
| October 26, 2026 | 52.22B |
| October 23, 2026 | 51.36B |
| October 22, 2026 | 51.95B |
| October 21, 2026 | 50.97B |
| October 20, 2026 | 50.91B |
| October 19, 2026 | 50.29B |
| October 16, 2026 | 49.93B |
| October 15, 2026 | 50.80B |
| October 14, 2026 | 49.85B |
| October 13, 2026 | 49.17B |
| October 12, 2026 | 49.81B |
| October 09, 2026 | 49.13B |
| Date | Value |
|---|---|
| October 08, 2026 | 48.57B |
| October 07, 2026 | 49.46B |
| October 06, 2026 | 49.86B |
| October 05, 2026 | 50.30B |
| October 02, 2026 | 49.10B |
| October 01, 2026 | 49.12B |
| September 30, 2026 | 49.77B |
| September 29, 2026 | 50.79B |
| September 28, 2026 | 50.07B |
| September 25, 2026 | 49.75B |
| September 24, 2026 | 49.43B |
| September 23, 2026 | 50.06B |
| September 22, 2026 | 51.19B |
| September 21, 2026 | 50.94B |
| September 18, 2026 | 50.89B |
| September 17, 2026 | 50.88B |
| September 16, 2026 | 51.48B |
| September 15, 2026 | 49.44B |
| September 14, 2026 | 49.31B |
| September 11, 2026 | 48.65B |
| September 10, 2026 | 50.03B |
| September 09, 2026 | 49.69B |
| September 08, 2026 | 50.00B |
| September 04, 2026 | 51.84B |
| September 03, 2026 | 51.77B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intuitive Surgical, Inc. | 153.74B |
| Stryker Corp. | 117.87B |
| Abbott Laboratories | 187.93B |
| Boston Scientific Corp. | 64.28B |
| Glaukos Corp. | 14.53B |
Market Cap Related Metrics
| PE Ratio | 62.42 |
| PS Ratio | 9.304 |
| Price to Book Value | 5.680 |
| Price to Free Cash Flow | 43.61 |
| Price | 107.18 |
| Earnings Yield | 1.60% |
| Operating PE Ratio | 32.00 |
| Normalized PE Ratio | 42.47 |